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Abstract 
Background: A birth defect is a structural or functional abnormality observed in children. Birth defects occur 
during intrauterine development of embryo or fetus. Birth defects may be visible before birth, at birth or later in 
life, and are major causes of children’s hospital admissions and deaths. 
Objectives: The aim of this study was to assess the prevalence and identify the associated risk factors of birth 
defects. 
Method: A retrospective cross-sectional study was conducted in two referral hospitals where 19,650 infants were 
born between 2015 and 2017. Among these, 317 infants born with birth defects were selected, and the types of 
birth defect were identified. To identify associated risk factors, 321 maternal medical history books were selected 
by simple random sampling. The data were collected using a semi-structured checklist. 
Results: A total of 19,650 infants were delivered during the study period. Among these, 1.61% of the infants had 
birth defects. The most frequent types of birth defect were neural tube defects (32.5%), followed by oro-facial 
clefts (27.1%), cardiovascular system defects (12%) and upper and lower limb defects (8.8%). Lack of folic acid 
supplementation (95% CI: 3.54-12.08), presence of chronic disease (95% CI: 2.27-7.21), intake of drugs (95% CI: 
1.98-6.38) and consumption of alcohol during pregnancy (95% CI: 1.13-3.60) were significantly associated with 
birth defects.  
Conclusion: The study identified a high prevalence of birth defects in infants born in Northwest Ethiopia. The 
most frequent type of birth defect was neural tube defect. In addition, the absence of maternal folic acid 
supplementation and the presence of chronic diseases during pregnancy were among the risk factors significantly 
associated with birth defects. Further detailed, nationwide, multicenter, retrospective/prospective follow up 
investigations should be conducted to influence political and healthcare decision-making so as to reduce birth 
defects.  [Ethiop. J. Health Dev.  2018;32(3):00-000] 
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Introduction 
Developmental disorders during delivery are described 
using different terms, such as birth defects (BDs), 
congenital malformation and anatomic abnormalities 
(1). A birth defect can be defined as an absence of 
structures and functions that normally form during the 
development of the embryo. It may be recognized 
prenatally, during delivery or in postnatal 
developments. The clinical conditions associated with 
BDs are usually observable during delivery. The 
frequent types of birth defect are congenital heart 
disease (CHD), neural tube defects (NTDs), oro-facial 
clefts (OFCs) and upper and lower limb defects (2, 3). 
 
In early human history, birth defects in both animals 
and humans were often attributed to a curse from God 
or because of evil. Even today, some cultures think that 
mothers who give birth to infants with BDs have had 
communication with a devil or evil spirits (4). 
 
Birth defects usually begin during organogenesis (from 
the 3rd to the 8th embryonic periods) (5). The cause of 
birth defects are not yet well known (1). However, the 
etiologies of birth defects are thought to be 
multifactorial inheritance, environmental teratogens, 
micronutrient deficiencies, chromosomal disorders and 
single gene defects. In developing countries, maternal 
infectious disease, such as rubella and syphilis, are 
purported to be common causes of birth defects (6). 
 
Globally, the prevalence of major birth defects was 4% 
to 6%. Among these, 2% to 3% are diagnosed in live-
born infants, and 2% to 3% are manifested in children 
around 5 years old (5). 
 
Worldwide, permanent disability and death of children 
are the results of the undesirable effects of birth 
defects. Annually, around 3.3 million children below 
the age of 5 die of birth defects. In addition, 303,000 
infants die within a month of being born because of 
birth defects, and 3.2 million live-born children are 
disabled for life, which has a direct impact on children, 
family, health care systems and communities (7). 
 
In both developed and developing countries, although 
BDs are the most serious cause of infant mortality and 
disability, about 94% of BDs, 95% of deaths and 15-
30% of hospital admissions of infants and children due 
to BDs are in low and middle income countries (8). 
One previously conducted prevalence study in 
Northwest Ethiopia, which included one of the 
hospitals in the present study, reported that the 
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prevalence of BDs was 1.9% (9). This indicates there is 
a relatively high prevalence of BDs in this 
geographical region of Ethiopia. 
The main aim of this study was to estimate the 
prevalence of BDs and to identify associated risk 
factors among newborn infants in two referral hospitals 
in Northwest Ethiopia, as there was very little data 
available, especially on associated factors. Moreover, a 
high level of prevalence of BDs was reported in the 
earlier study mentioned above, and the results from the 
current study would give an insight into the magnitude 
of the problem and provide baseline data for future 
detailed studies. In addition, information from this 
study would be useful in developing strategies for the 
prevention of birth defects as well as for improved 
management and rehabilitation of patients with BDs.  
 
Materials and methods 
Method of data collection:  The type of study was an 
institution-based, retrospective, cross-sectional study. 
The study was conducted in two governmental referral 
hospitals: Debre Markos referral hospital (DMRH) and 
Felege Hiwot referral hospital (FHRH), in East and 
West Gojjam zones of Amhara region, Ethiopia. These 
hospitals were selected based on patient load. Also, 
they are the only referral hospitals in the East and West 
Gojjam zones of Amhara region. 
 
Data collectors were selected in each of the two 
governmental hospitals, and they were trained for two 
days regarding the objectives of the study, about 
inclusion and exclusion criteria, and on sampling 
procedures. All 19,650 infants born between 2015 and 
2017 were included in the study. To identify the 
associated risk factors of BDs, a total of 346 computer-
generated samples were taken by simple random 
sampling from the total number of infants born. 
However, only 321 infants were included in the study 
based on the completeness of the data. Among these, 
104 infants were born with BDs and 217 infants were 
born with no BDs. Data were also collected on socio-
demographic and clinical information.  
 
Data were collected from hospital records between 
October 2017 and January 2018. In order to determine 
the magnitude of BDs and the associated risk factors, 
all 19,650 infants’ medical records were reviewed. The 
infants born with BDs were selected from a list 
containing the total number of infants born. The types 
of BD were identified based on maternal medical 
registration books. The data in medical history record 
books were collected by using a pre-tested semi-
structured checklist. The checklist included: maternal 
socio-demographic characteristics (age, occupation and 
residency), general features of infant (sex), type of BD, 
and the associated risk factors of BDs (maternal history 
of folic acid supplementation, maternal history of 
alcohol consumption, maternal history of disease and 
maternal history of drug use). 
 
The data were collected from delivery wards and 
neonatal intensive care units (NICUs) by the assigned 
data collectors (midwives) working at the study 
hospitals. Gynecologists/obstetricians and pediatricians 
were consulted when there was an ambiguous 
diagnosis. The proportions of children with BDs were 
calculated by dividing the number of birth BD cases 
(numerator) by the total number of live and stillborn 
infants (denominator). 
 
Data processing and analysis:  After checking for 
completeness, the data were entered into Epi-data 
version 3.1 and exported to SPSS version 24 for 
analysis.  
 
Descriptive statistics, such as frequency distribution, 
percentages and tables, were used to describe the socio-
demographic variables, the percentage of types of BD 
and the percentage of types of NTD. 
 
Bivariate followed by multivariable logistic regression 
analyses were carried out to determine factors 
associated with BDs. The 95% confidence interval was 
determined and a p-value less than 0.05 were 
considered as statistically significant in all of the 
analyses. 
 
Ethical consideration:  Ethical clearance was secured, 
prior to data collection, from the Departmental 
Research Ethics Review Committee (DRERC) of the 
Department of Bio-Medical Sciences, School of 
Medicine, Debre Markos University and from the 
Institute of Review Board (IRB) of the School of 
Medicine, College of Health Sciences, Addis Ababa 
University. The anonymity of the patients and 
confidentiality of the data were maintained by the 




Prevalence of birth defects:  In DMRH and FHRH, a 
total of 19,650 infants were born during the study 
period. In the context of our study, the study period is 
the ‘data collection period’ (October 2017 to January 
2018). Of the 19,650 infants, 317 (1.61%) had BDs. 
The proportion of male infants who had BDs was 
greater than that of female infants. The majority of 
infants with BDs were rural residents (55.2%), 
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Table 1:  The socio-demographic characteristics of study subjects in FHRH* and DMRH***, 2018 
Variables FHRH DMRH Total 
  number  % number % number % 
Gender  Male 86 46.0 101 54.0 187 59.0 
Female  77 59.2 53 40.8 130 41.0 
Age  <35 years  58 55.2 47 44.8 105 33.1 
>35 years 105 49.5 107 50.5 212 66.9 
Residence   Urban  72 50.7 70 49.3 142 44.8 
Rural  91 52.0 84 48.0 175 55.2 
Occupation  Farmer  88 50.9 85 49.1 173 54.6 
Government 
employee  
24 49.0 25 51.0 49 15.4 
Private employee 38 55.9 30 44.1 68 21.5 
Unspecified  13 48.1 14 51.9 27 8.5 
*FHRH = Felege Hiwot referral hospital; **DMRH = Debre Markos referral hospital 
 
Types of birth defects:  Among the 317 infants 
diagnosed with BDs, the most frequent types of BD 
were neural tube defects (NTDs) (32.5%), followed by 
oro-facial clefts (OFCs) (27.1%), cardiovascular 
system defects (CVSDs) (12%), upper and lower limb 
defects (8.8%), digestive and abdominal wall defects 
(6.6%), unspecified congenital malformation (5.4%), 
Down syndrome (3.2%), genitourinary system defects 




Table 2:  The frequency distribution of BD by sex from 2015-2017 in FHRH and DMRH, 2018 
Variables  Male number 
(n=187) 
% Female number 
(n=130) 
% Total number 
(n=317) 
% 
Neural tube defects 59 31.6 44 33.8 103 32.5 
Oro-facial clefts 51 27.3 35 26.9 86 27.1 
Cardiovascular system 
defects 
22 11.8 16 12.3 38 12.0 
Upper and lower limb 
defects 
19 10.2 9 6.9 28 8.8 
Digestive and 
abdominal wall defects 
13 7.0 8 6.2 21 6.6 
Unspecified congenital 
malformation  
11 5.9 6 4.6 17 5.4 
Down syndrome 6 3.2 4 3.1 10 3.2 
Genitourinary system 
defects 
4 2.1 5 3.8 9 2.8 
Head, face and neck 
defects 
2 1.1 3 2.3 5 1.6 
 
Types of neural tube defects:  As indicated in Table 3, 
among the neural tube defects, spina bifida with or 
without menigocele/menigomyelocele was the most 
common (51.5%), followed by hydrocephaly (34.9%), 
anencephaly (6.8%), spina bifida with hydrocephaly 
(3.9%) and others (2.9%). 
Factors associated with birth defects:  As indicated in 
Table 4 and Table 5, absence of maternal folic acid 
supplementation, maternal history of chronic disease, 
history of medication and history of alcohol 
consumption during pregnancy were significantly 
associated with BDs. 
 
Table 3:  The frequency of neural tube defects (NTDs) from 2015-2017 in FHRH and DMRH, 2018 
Variables  Frequency (n=103)  % 
Spina bifida (lumbar, sacral, thoracic and cervical) 53 51.5 
Hydrocephaly  36 34.9 
Anencephaly  7 6.8 
Spina bifida with hydrocephaly  4 3.9 
Others* 3 2.9 
*Spina bifida with cardiovascular system defects and anencephaly with limb defects.  
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Table 4:  The associated factors of birth defects in study subjects in FHEH and DMRH, 2018 
Variables  Frequency 
(n=321) 
% 
Maternal folic acid supplement Yes 188 58.6 
No 133 41.4 
Maternal history of alcohol intake Yes 167 52.0 
No 154 48.0 
Maternal history of chronic disease Yes 142 44.2 
No 179 55.8 
Types of chronic disease*  DM 53 37.3 
HIV/AIDS 44 31.0 
HTN 28 19.7 
Epilepsy  13 9.2 
CKD 4 2.8 
Maternal history of medication Yes 158 49.2 
No 163 50.8 
Types of drug  Antiretroviral 35 22.2 
Insulin  32 20.3 
Antiepileptic 8 5.1 
Antihypertensive  21 13.3 
Drug name not recorded  62 39.2 
Family history of BD Yes 153 47.7 
No 168 52.3 
*DM (diabetes miletus), HIV/AIDS (human immunodeficiency virus/acquired immune deficiency syndrome), HTN 
(hypertension), CKD (chronic kidney disease) 
 
Infants born from mothers who did not have folic acid 
supplementation during pregnancy were 6.54 times 
[AOR = 6.54, 95% CI: 3.54-12.08)] more likely to 
have BDs compared to those who had folic acid 
supplementation. Infants of mothers who had a chronic 
disease during pregnancy, who took drugs or who had 
consumed alcohol during pregnancy were 4.05 times 
[AOR = 4.05, 95% CI: 2.27-7.21)], 3.55 times [AOR = 
3.55, 95% CI: 1.98-6.38)] and 2.02 times [AOR = 2.02, 
95% C: 1.13-3.60)], respectively, more likely to have 
BDs (Table 5). 
 
Table 5:  Multivariate analysis of risk factors for birth defects (BDs) in study subjects in FHRH and DMRH, 
2018 
Variables   Birth defect COR* (95% CI) AOR** (95% CI) p-value 
Yes No 
Sex of infants  Male  60 129 0.93 (0.58-1.49) 0.68 (0.38-1.21) 0.190 
Female  44 88 1 1  
Family residence  Urban  47 97 1.02 (0.64-1.63) 1.66 (0.90-3.04) 0.103 
Rural  57 120 1 1  
Maternal folic acid 
supplementation during 
this pregnancy 
Yes 33 155 1 1  
No 71 62 5.38 (3.23-8.93) 6.54 (3.54-12.08) 0.000 
Maternal history of alcohol 
during this pregnancy  
Yes 62 105 1.58 (0.981-2.53) 2.02 (1.13-3.60) 0.018 
No 42 112 1 1  
Maternal history of chronic 
disease   
Yes 72 70 4.72 (2.85-7.82) 4.05 (2.27-7.21) 0.000 
No 32 147 1 1  
Maternal history medication 
during pregnancy  
Yes 73 31 3.66 (2.22-6.03) 3.55 (1.98-6.38) 0.000 
No 31 132 1 1  
*COR = crude odds ratio; **AOR = adjusted odds ratio (adjusted for socio-demographic and other 
associated factors) 
Discussion 
The present study has observed a high prevalence of 
BDs among newly born infants and identified the 
associated risk factors. The most frequent types of BD 
were neural tube defects, followed by oro-facial clefts, 
cardiovascular system defects and upper and lower 
limb defects. A lack of folic acid supplementation, 
presence of chronic disease, intake of drugs and 
alcohol consumption during pregnancy were 
significantly associated with birth defects. 
 
The current research findings are in line with a study of 
newborn infants conducted in the city of São Paulo, 
Brazil, which showed a BD prevalence of 1.6% (10). 
However, the prevalence of BDs observed in the 
present study was slightly less than that reported in 
another prevalence study conducted in Ethiopia 
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(1.96%) (9). This discrepancy might be due to the fact 
that this study included two national referral hospitals, 
including the Black Lion Hospital, where cases from 
different parts of the country are referred to for 
treatment and better management. A lower prevalence 
of BDs (12.5 per 1,000 live births) has been reported 
by a study carried out in India, where the data were 
collected from a single hospital (11). A much higher 
prevalence of BDs (4.1%) has been reported in a study 
conducted in Pakistan (12). This could be explained by 
the fact that the study was conducted in a hospital 
setting where only those infants who needed special 
care were admitted. 
 
The current study shows that BDs were more frequent 
in males (59%) than in females (41%), which is in 
agreement with the finding of another study conducted 
in Ethiopia (58.5%) (9). 
 
The most common form of BD was NTD, followed by 
OFC, while the least frequent were genitourinary 
system defects and head, face and neck defects, 
respectively. Similar frequencies of types of BD have 
been reported in studies conducted in Tanzania and 
Nigeria (13, 14). However, in a previous study 
conducted in Ethiopia (9), OFC was the most frequent 
type of BD, albeit by a slight margin. This may be 
expected, given that the study included the Black Lion 
Hospital, where as noted above, BD cases, including 
OFC, from different parts of the country are referred to 
for treatment and better management. On the other 
hand, infants born with NTDs are usually still births. 
Other investigations have reported that upper and lower 
limb defects (15) and congenital heart defects (16, 17), 
respectively, are the most prevalent BDs. These 
inconsistencies may be due to different maternal 
exposures to teratogens.  
   
The present study shows that there is strong 
relationship between the prevalence of BDs and the 
lack of maternal folic acid supplementation during 
pregnancy, the presence of chronic disease, the intake 
of drugs, and the consumption of alcohol during 
pregnancy. Infants born from mothers who did not get 
folic acid supplementation during pregnancy were 6.54 
times more likely to have BDs compared to infants 
born from mothers who took folic acid 
supplementation. This finding is in agreement with a 
study which reports that folic acid opponent drugs 
increase the possibility of BD, and that folic acid 
supplementation lowers the risk of BDs (18). Our 
finding is also in accordance with a study conducted in 
Texas, which reports that maternal folic acid 
supplementation significantly decreases the prevalence 
of NTDs (19). Maternal folic acid supplementation, 
especially one month before pregnancy and throughout 
the first trimester, significantly decreases BDs, mainly 
NTDs (20-23). In Ethiopia, the magnitude of NTDs is 
relatively high, which may be attributed to the low 
coverage of maternal folic acid usage (1.92%) (24). 
Even though, in Ethiopia, the policy for folic acid 
allocation is well established by the Federal Ministry of 
Health, pregnant mothers’ folic acid usage is still low. 
This might be due to the lack of knowledge of health 
care providers, the community and pregnant mothers in 
terms of the importance of maternal folic acid 
supplementation during pregnancy (24). 
 
Infants born from mothers who had a chronic disease 
during pregnancy were 4.05 times more likely to have 
BDs compared to infants born from mothers who did 
not have chronic diseases. The presence of chronic 
disease during pregnancy as a risk factor for BD is 
documented in text books (1). The finding of our 
investigation was also supported by studies conducted 
in Pakistan (25) and in the USA (26). Another study 
conducted in Canada also reported that several chronic 
maternal diseases, including diabetes, hypertension, 
connective tissue disorders and congenital heart disease 
confer an increased risk of BDs in offspring (27). 
Unlike our findings, however, research conducted in 
California reports that the magnitude of infants born 
with BDs from mothers who had chronic diseases was 
relatively low (28). A lack of clear knowledge about 
exactly when in the embryonic periods pregnant 
mothers develop chronic disease may be a factor in this 
discrepancy. 
 
Another factor that had a significant association with 
BDs in the current study was maternal intake of drugs 
during pregnancy. Infants born from mothers who took 
drugs during pregnancy were 3.55 times more likely to 
have a BD compared to infants born from mothers who 
did not take any types of drug during pregnancy. This 
finding is congruent with the findings of other studies 
which report that maternal exposure to nitrate from 
drinking water and diet are risk factors for BDs (1, 29). 
The consumption of both prescribed and self-
administered drugs during pregnancy have adverse 
effects on the development of the fetus (30).  
 
Moreover, infants born from mothers who consumed 
alcohol during pregnancy were found to be 2.02 times 
more likely to have BDs compared to infants born from 
mothers who did not. Pregnant mothers drinking any 
amount of alcohol during early pregnancy had direct 
effects on the growth and morphogenesis of fetuses 
(31-33). In a study of rats, the use of an ethanol liquid 
diet for one month prior to conception and during 
development distorted the usual blueprint of 
myelination in rat progeny. It is highly likely that 
myelin developmental disorders cause other BDs (32). 
 
Conclusions:  
The present study has observed a comparatively high 
prevalence of BDs among newborn infants. Male 
infants were more likely to have BDs compared to 
females. The most frequent types of BD were NTDs 
followed by OFCs. Among NTDs cases identified, 
spina bifida was the most frequent. Absence of 
maternal folic acid supplementation during pregnancy, 
presence of chronic diseases, intake of drugs and 
consumption of alcohol during pregnancy were 
significant risk factors for the development of BDs. 
  
The findings of the current investigation have shown 
that the prevalence of BDs in the East and West 
Gojjam zones of Northwest Ethiopia is unacceptably 
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high. Therefore, educating women of reproductive age 
and the community at large on BDs and the associated 
risk factors is critical, as lack of awareness is a major 
problem in the area. 
 
The present study has given an insight into the 
magnitude of the problem of BDs and provided 
baseline data for future detailed studies, as there was 
very little data available previously. In addition, 
information from this study would be useful in 
developing strategies for the prevention of birth defects 
as well as for improved management and rehabilitation 
of surviving victims of BDs. Further detailed, 
nationwide, multicenter, retrospective/prospective 
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